India pushes Phase-VI HIV plan as infections fall nationwide
India pushes Phase-VI HIV plan as infections fall nationwide
As India rolls out NACP Phase-VI, officials report sharp drops in new infections and deaths, while warning of rising hotspots linked to injecting drug use.
India stands at a turning point in its battle against HIV/AIDS. Four decades after the first case was reported, the country has built one of the world’s most expansive and resilient national HIV prevention and treatment programmes. The National AIDS and STD Control Programme (NACP) has shown undeniable gains: new infections have fallen by nearly half since 2010, AIDS-related deaths have dropped by more than 80%, viral suppression now exceeds 97% among those on treatment, and India has transitioned entirely onto Dolutegravir-based regimens — placing it among the global leaders in treatment efficacy. There are still hurdles, however, and there can be no room for complacency.
As the country transitions into the NACP Phase-VI for 2026-31, it must confront the reality that India’s epidemic is still evolving, and in some places, is accelerating. The overall low national prevalence of 0.20% masks emerging hotspots and newer vulnerabilities. States such as Assam, Arunachal Pradesh, Tripura and Punjab have reported rising incidence, driven largely by injecting drug use. Among people who inject drugs, HIV prevalence is 40 times the national average, with some hotspots reporting exponential increases. With an estimated one-in-160 chance of transmission from a single needle-sharing event, epidemics linked to injecting drug use can spiral rapidly if not responded effectively. In addition, a growing proportion of new infections now occur among individuals acquiring HIV from casual or regular partners — signalling a shift beyond traditional core groups. India’s young demographic — 2.25 crore adolescents entering the 15-25 year age cohort annually — remains vulnerable with easy access to digital platforms, enabling risky sexual behaviour and substance use. India has made substantial gains in reducing vertical transmission. Universal screening and treatment of antenatal mothers for HIV and syphilis have been implemented.
Recent progress is reflected in states like Telangana, where data show a 58% reduction in new HIV infections thanks to expanded testing and a push to broaden access to ART. The example underscores how targeted testing and treatment expansion can translate into real, life-saving declines even as the national picture remains uneven.
AIDS organisations and health advocates say the phase transition must be paired with intensified measures to push toward zero infections. As patterns evolve and new vulnerabilities appear, policy-makers are urged to protect hard-to-reach populations, ensure continuous drug supply, and strengthen community engagement to sustain gains and close remaining gaps.
Taken together, the push toward Phase-VI signals a determined bid to sustain progress while confronting hotspots and shifting risk factors. With continued emphasis on universal testing, affordable treatment, and youth-focused prevention, India aims to keep bending the curve on HIV and move closer to an AIDS-free generation.
Cover image source: HIV prevalence falls in Telangana; expanded testing, ART push State toward 2030 AIDS-free goal 🔗
